Today in News History

On July 13, several notable moments in the history of News stand out. In 1913, The 1913 Romanian Army cholera outbreak during the Second Balkan War starts. In 1943, Chris Serle, English journalist and actor was born. In 1961, Tim Watson, Australian footballer, coach, and journalist was born. In 1973, Watergate scandal: Alexander Butterfield reveals the existence of a secret Oval Office taping system to investigators for the Senate Watergate Committee. In 1985, The Live Aid benefit concert takes place in London and Philadelphia, as well as other venues such as Moscow and Sydney. In 1989, Charis Giannopoulos, Greek basketball player was born. In 1995, Space Shuttle Discovery is launched on STS-70 to deploy the TDRS-7 satellite. In 2003, French DGSE personnel abort an operation to rescue Íngrid Betancourt from FARC rebels in Colombia, causing a political scandal when details are leaked to the press. In 2010, George Steinbrenner, American businessman (born 1930) passed away. In 2020, Grant Imahara, American electrical engineer, roboticist, and television host (born 1970) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.

EU launches probe into Sanofi over flu vaccine marketing

BOL News

BOL News

·

June 27, 2026

·

lean right

Flu vaccines are an important business area for Sanofi, especially in France where they are widely used in national vaccination programs The post EU launches probe into Sanofi over flu vaccine marketing appeared first on BOL News.

Narrative Intelligence Brief

This article was published by BOL News, a source frequently categorized with a lean right bias based in Pakistan. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of BOL News, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.

Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.

How other outlets are covering this story

Compare narratives across 27 related reports from 27 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.

Coverage bias distribution

27 sources

Left 37%

Center 30%

Right 30%


The Motley Fool

lean left

· Jul 3, 2026

Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?

Moderna expands beyond vaccines while Recursion bets on AI-driven drug discovery, each with distinct risks, partnerships, and financial profiles.

Bloomberg

lean left

· Jun 25, 2026

Moderna CEO: Cautiously Optimistic on Flu Vaccine Approval

The FDA advisory committee recommended Moderna's flu vaccine for approval. Moderna CEO Stéphane Bancel tells Romaine Bostick and Katie Greifeld he is cautiously optimistic the approval will happen. (Source: Bloomberg)

Le Monde

lean left

· Jun 26, 2026

EU hits France's Sanofi with flu vaccine antitrust probe

The investigation centers on how the firm marketed an enhanced flu vaccine, offered under the brand name Efluelda and designed to provide greater protection for people over 60.

The korea Herald News

center

· Jul 7, 2026

Matica Bio, VaxDome partner on antiviral hybrid vaccine development

Matica Biotechnology, the US contract development and manufacturing organization subsidiary of CHA Biotech, has partnered with Texas-based VaxDome Inc. to jointly develop an antigen-agnostic antiviral vaccine aimed at protecting against a broad range of infectious diseases. The collaboration will focus on advancing VaxDome's hybrid antiviral vaccine candidates into clinical trials. Under the agreement, Matica Biotechnology will provide process development, analytical development and the producti

NaturalNews.com

right

· Jun 30, 2026

Pharma-Funded Campaign Silenced Online Vaccine Dissent, Documents Reveal

(NaturalNews) A coordinated campaign funded by pharmaceutical interests targeted healthcare workers who questioned Wuhan coronavirus (COVID-19) vaccines, according ...

Seeking Alpha

lean right

· Jun 24, 2026

Moderna: Flu Vaccine Progress Is Only Part Of The Story

Moderna: Flu Vaccine Progress Is Only Part Of The Story

FOX News Health

right

· Jul 6, 2026

Experimental vaccine shows promise against dangerous intestinal illness

New ETEC vaccine technology targeting enterotoxigenic Escherichia coli has been licensed to Valneva after decades of research at University of Bergen.

Vogue

left

· Jun 26, 2026

Is Bodycare Luxury Beauty’s Next Frontier?

The bodycare category is booming as more brands enter the space and players such as L’Oréal’s Bold and Advent International invest early.

Investing.com

center

· Jul 12, 2026

Evaxion presents preclinical data on CMV vaccine candidate

Evaxion presents preclinical data on CMV vaccine candidate

UrduPoint

lean right

· Jun 23, 2026

Abu Dhabi's Department of Health, Sanofi partner to advance vaccine innovation

Abu Dhabi's Department of Health, Sanofi partner to advance vaccine innovation

South Africa Today

right

· Jun 29, 2026

Bitget Upgrades CFD Copy Trading With Personalized Risk Controls

(GLOBE NEWSWIRE) — Bitget, the world’s largest Universal Exchange (UEX), has introduced major upgrades to its CFD Copy Trading system, giving followers greater control over risk management through new position sizing models, independent take-profit and stop-loss settings, and advanced exposure controls. Copy trading has become one of the most popular ways for users to participate in []

Financial Times

center

· Jul 5, 2026

Regulators in ‘arms race’ to keep up with AI use in financial services, says UK official

Warning by FCA executive director comes as millions of people use technology to make personal finance decisions

Korea Times News

lean left

· Jul 2, 2026

SK bioscience, Gates Foundation to launch AI-driven vaccine platform

SK bioscience, Gates Foundation to launch AI-driven vaccine platform

Foreign Policy Journal

left

· Jun 23, 2026

Jim Cramer Issues Conviction Buy On SoFi Technologies (NASDAQ: SOFI) Stock As CEO Loads Up

SoFi Technologies (NASDAQ: SOFI) is drawing renewed investor attention after CNBC’s Jim Cramer issued a pointed buy call on the digital bank during his Mad Money Lightning Round on June 18. Cramer was unambiguous in his assessment of the stock, stating: “It’s hanging around that level. I continue to believe it’s time to buy.” The [] The post Jim Cramer Issues Conviction Buy On SoFi Technologies (NASDAQ: SOFI) Stock As CEO Loads Up appeared first on Foreign Policy Journal.

Medical Daily

center

· Jun 25, 2026

FDA Panel Backs Moderna's First mRNA Flu Shot — What It Could Mean for Your Fall Vaccine

FDA advisers unanimously backed Moderna's mRNA flu vaccine mFlusiva on June 18. Here's what the 9-0 vote means for fall 2026 vaccination and who it would cover.

Ars Technica

Unknown

· Jun 26, 2026

Antibiotic "megacluster" discovery provides new strategy to fight superbugs

It's an exciting advance in efforts to restock the antibiotic arsenal.

India News Network

lean right

· Jul 13, 2026

Antimicrobial Resistance Poses Rising Threat to Surgical Care

Experts warn that antibiotic resistance is now a major threat to surgical procedures globally, increasing risks of post-operative infections.

The Eastern Herald

center

· Jul 8, 2026

Vertex’s $10 Billion Crinetics Takeover Signals Pharma’s Biggest Rare Disease Bet Yet

Vertex Pharmaceuticals is making its largest acquisition ever, placing a massive 10 billion bet on rare endocrine diseases with the purchase of Crinetics Pharmaceuticals. The deal marks a major strategic shift for the biotechnology leader, which has built its empire around cystic fibrosis treatments but is now expanding aggressively into new high-value therapeutic areas. Under the agreement, Vertex will acquire Crinetics for 85 per share in cash, representing an equity value of approximately 10 billion. The transaction is expected to close in the third quarter of 2026 after receiving customary regulatory approvals. The acquisition gives Vertex access to Crinetics’ growing

Inc.com

center

· Jul 1, 2026

How Walmart Unexpectedly Became One of the World Cup’s Hottest Tourist Attractions

The retailer is capitalizing on its popularity with football fans with a new marketing strategy.

The Epoch Times

right

· Jul 9, 2026

LIVE NOW: FDA Roundtable Examines E. Coli Food Safety Risks

The U.S. Food and Drug Administration (FDA) hosts a roundtable at 12 p.m. ET on July 9 on insights from an environmental longitudinal study examining the spread and persistence of Shiga toxin-producing E. coli (STEC) across California’s Central Coastal agricultural region. FDA researchers Julie Ann Kase and Susan R. Leonard will discuss food safety risks, []

Utusan Malaysia

center

· Jun 23, 2026

Akses perlindungan kesihatan digital lebih mudah dengan Kaotim MediKad

KOS rawatan kesihatan yang semakin meningkat ketika ini membuatkan ramai mula memberi perhatian terhadap kepentingan perlindungan perubatan, khusus­nya pelan yang lebih mudah di­akses dan tidak membebankan komitmen bulanan. Seiring perubahan gaya hidup digital, Kaotim MediKad di­per­kenalkan oleh Syarikat Ta­ka­ful Malaysia Keluarga Berhad (Ta­kaful Malaysia) sebagai pilihan perlindungan perubatan yang lebih ringkas, pantas dan mesra pengguna. Pelan ... Read more The post Akses perlindungan kesihatan digital lebih mudah dengan Kaotim MediKad appeared first on Utusan Malaysia.

The Japan Times

center

· Jul 1, 2026

Panasonic targets further AI growth to build on record valuation

The Japanese electronics conglomerate is attracting renewed investor attention as a beneficiary of the artificial-intelligence boom.

NPR Topics: Health

lean left

· Jun 27, 2026

If a Lyme disease vaccine gets approved, how would it go over? We asked hunters

Drugmakers are working on a potential new shot to prevent the tick-borne illness. How might it fare in the era of vaccine skepticism?

Lawyers, Guns & Money

left

· Jun 25, 2026

Goodbye, Scientific American!

Scientific American has been acquired by LabX Media Group, which holds Discover Magazine, IFLScience, and a number of other science publications. I haven’t looked at IFLScience since it was a Twitter account stealing other people’s material. They say it’s different now. And they have started out by firing writers and editors. The Writers Guild of [] The post Goodbye, Scientific American! appeared first on Lawyers, Guns Money.

Vanity Fair

left

· Jul 2, 2026

MAGA Makeup or Lefty Lipstick? What Your Cosmetics Say About Your Politics

The brands we put on our faces and bodies—Agent Nateur to MAC—are just as divided as every other cultural and political aspect of the United States.

The West Australian

lean right

· Jun 30, 2026

State Government expands FluMist nasal spray flu vaccination program to include children aged 12-17

After a successful rollout for younger children, the State Government is expanding the FluMist program, making the needle-free influenza vaccine available for children and teenagers aged 12-17.

Metro

lean left

· Jul 2, 2026

M&S shoppers are obsessed with Per Una’s new boho-inspired summer collection

From crochet dresses to denim shorts, these MS buys will sell fast.

Topics:

World · 12
Business · 4
Health · 4
Politics · 4
Lifestyle · 1

Related coverage for "EU launches probe into Sanofi over flu vaccine marketing": The Motley Fool — Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?. Bloomberg — Moderna CEO: Cautiously Optimistic on Flu Vaccine Approval. Le Monde — EU hits France's Sanofi with flu vaccine antitrust probe. The korea Herald News — Matica Bio, VaxDome partner on antiviral hybrid vaccine development. NaturalNews.com — Pharma-Funded Campaign Silenced Online Vaccine Dissent, Documents Reveal. Seeking Alpha — Moderna: Flu Vaccine Progress Is Only Part Of The Story. FOX News Health — Experimental vaccine shows promise against dangerous intestinal illness. Vogue — Is Bodycare Luxury Beauty’s Next Frontier?. Investing.com — Evaxion presents preclinical data on CMV vaccine candidate. UrduPoint — Abu Dhabi's Department of Health, Sanofi partner to advance vaccine innovation. South Africa Today — Bitget Upgrades CFD Copy Trading With Personalized Risk Controls. Financial Times — Regulators in ‘arms race’ to keep up with AI use in financial services, says UK official. Korea Times News — SK bioscience, Gates Foundation to launch AI-driven vaccine platform. Foreign Policy Journal — Jim Cramer Issues Conviction Buy On SoFi Technologies (NASDAQ: SOFI) Stock As CEO Loads Up. Medical Daily — FDA Panel Backs Moderna's First mRNA Flu Shot — What It Could Mean for Your Fall Vaccine. Ars Technica — Antibiotic "megacluster" discovery provides new strategy to fight superbugs. India News Network — Antimicrobial Resistance Poses Rising Threat to Surgical Care. The Eastern Herald — Vertex’s $10 Billion Crinetics Takeover Signals Pharma’s Biggest Rare Disease Bet Yet. Inc.com — How Walmart Unexpectedly Became One of the World Cup’s Hottest Tourist Attractions. The Epoch Times — LIVE NOW: FDA Roundtable Examines E. Coli Food Safety Risks. Utusan Malaysia — Akses perlindungan kesihatan digital lebih mudah dengan Kaotim MediKad. The Japan Times — Panasonic targets further AI growth to build on record valuation . NPR Topics: Health — If a Lyme disease vaccine gets approved, how would it go over? We asked hunters. Lawyers, Guns & Money — Goodbye, Scientific American!. Vanity Fair — MAGA Makeup or Lefty Lipstick? What Your Cosmetics Say About Your Politics. The West Australian — State Government expands FluMist nasal spray flu vaccination program to include children aged 12-17. Metro — M&S shoppers are obsessed with Per Una’s new boho-inspired summer collection